Travere Therapeutics is rated Buy, with a DCF-based fair value of ~$81 per share, implying 27% upside. Click here to read ...
Detailed price information for Travere Therapeutics Inc (TVTX-Q) from The Globe and Mail including charting and trades.
Investor's Business Daily on MSN
IBD stock of the day, Travere Therapeutics, tests another breakout. Can the stock get any 'sweeter?'
Travere Therapeutics is Friday's IBD Stock Of The Day. As the Filspari story gets "sweeter," shares are clearing a fresh buy ...
The Nomura Small Cap Core Fund trailed its benchmark in Q2 2026 despite an exceptionally strong rally in small-cap stocks. Read the full analysis for more details.
Investor's Business Daily on MSN
Guardant Health dives after losing a patent dispute; judge orders royalties
Guardant Health stock tumbled Monday after losing a patent battle against privately held TwinStrand Biosciences.
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
过去一周，全球生物医药市场被一则重磅临床数据彻底激活。Moderna联合默沙东公布关键Ⅲ期数据：个性化新抗原mRNA肿瘤疫苗mRNA-4157联合K药，作为术后辅助手段，能够显著压低患者复发、转移的风险，展现出划时代的疗效。消息一出，Moderna单 ...
Travere Therapeutics Inc. Annual cash flow by MarketWatch. View TVTX net cash flow, operating cash flow, operating expenses and cash dividends.
Ligand Pharmaceuticals Inc () has held its Q2 earnings call. Read on for the main highlights of the call. Summer Sale - Claim 70% Off TipRanks. Unlock powerful investing tools wit ...
Dette er Nesbø-stilen slik vi kjenner den best: Tett, effektiv og velkomponert. Nesbø vant i år sin tredje Rivertonpris for ...
8月19日，港股创新药企业云顶新耀(01952.HK)披露2026年中期业绩。报告期内，公司实现总收入人民币11.48亿元，同比增长157%；剔除非现金项目后毛利率达到73.7%，非国际财务报告准则下实现净利润人民币9723万元，标志着 ...
Everest Medicines (HKEX 1952.HK, Everest, or the Company), a biopharmaceutical company focused on the discovery, clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results